Teva Pharmaceutical Industries Ltd.

Director's Dealing • Sep 4, 2020

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden hours
per response	0.5

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person			2. Date of Event Requiring		3. Issuer Name and Ticker or Trading Symbol
Hussain	Abbas		Statement (Month/Day/Year)		Teva Pharmaceutical Industries Ltd. [TEVA]
(Last) Basel street	(First) C/O Teva Pharmacetical Industries Ltd.	(Middle) , 5		09/01/2020	Issuer		4. Relationship of Reporting Person(s) to (Check all applicable) ____ 10% Owner		5. If Amendment, Date Original Filed(Month/Day/Year)
(Street) Petach Tikva (City)	L3 (State)	4951033 (Zip)			X Director ____ Officer (give title below)	below)	____ Other (specify		6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person ____ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)			2. Amount of Securities Beneficially Owned (Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)		(Instr. 5)	4. Nature of Indirect Beneficial Ownership

Ordinary Shares (1) 0 D

Table II - Derivative Securities Beneficially Owned ( e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		(Instr. 4)	3. Title and Amount of Securities Underlying Derivative Security	4. Conversion or Exercise Price of Derivative	5. Ownership Form of Derivative	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	Security	Security: Direct (D) or Indirect (I) (Instr. 5)

Explanation of Responses:

(1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

/s/ Dov Bergwerk as attorney-in-fact for Abbas Hussain 09/03/2020 **Signature of Reporting Person Date

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.